122 related articles for article (PubMed ID: 30187046)
1. A tetravalent sialic acid-coated tetraphenylethene luminogen with aggregation-induced emission characteristics: design, synthesis and application for sialidase activity assay, high-throughput screening of sialidase inhibitors and diagnosis of bacterial vaginosis.
Liu GJ; Wang B; Zhang Y; Xing GW; Yang X; Wang S
Chem Commun (Camb); 2018 Sep; 54(76):10691-10694. PubMed ID: 30187046
[TBL] [Abstract][Full Text] [Related]
2. 2,3-Didehydro-2-deoxysialic acids structurally varied at C-5 and their behaviour towards the sialidase from Vibrio cholerae.
Schreiner E; Zbiral E; Kleineidam RG; Schauer R
Carbohydr Res; 1991 Sep; 216():61-6. PubMed ID: 1797392
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of delta4-beta-D-glucopyranosiduronic acids as mimetics of 2,3-unsaturated sialic acids for sialidase inhibition.
Florio P; Thomson RJ; Alafaci A; Abo S; von Itzstein M
Bioorg Med Chem Lett; 1999 Jul; 9(14):2065-8. PubMed ID: 10450982
[TBL] [Abstract][Full Text] [Related]
4. 9-Azido-9-deoxy-2,3-difluorosialic Acid as a Subnanomolar Inhibitor against Bacterial Sialidases.
Li W; Santra A; Yu H; Slack TJ; Muthana MM; Shi D; Liu Y; Chen X
J Org Chem; 2019 Jun; 84(11):6697-6708. PubMed ID: 31083938
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of selective inhibitors against V. cholerae sialidase and human cytosolic sialidase NEU2.
Khedri Z; Li Y; Cao H; Qu J; Yu H; Muthana MM; Chen X
Org Biomol Chem; 2012 Aug; 10(30):6112-20. PubMed ID: 22641268
[TBL] [Abstract][Full Text] [Related]
6. A unique sialidase that cleaves the Neu5Gcalpha2-->5-O(glycolyl)Neu5Gc linkage: comparison of its specificity with that of three microbial sialidases toward four sialic acid dimers.
Inoue S; Lin SL; Inoue Y; Groves DR; Thomson RJ; von Itzstein M; Pavlova NV; Li SC; Li YT
Biochem Biophys Res Commun; 2001 Jan; 280(1):104-9. PubMed ID: 11162485
[TBL] [Abstract][Full Text] [Related]
7. Sialidase Inhibitors with Different Mechanisms.
Keil JM; Rafn GR; Turan IM; Aljohani MA; Sahebjam-Atabaki R; Sun XL
J Med Chem; 2022 Oct; 65(20):13574-13593. PubMed ID: 36252951
[TBL] [Abstract][Full Text] [Related]
8. Release of sialic acid from substrates by sialidase in the presence of H2[18O].
Deijl CM; Kamerling JP; Vliegenthart JF
Carbohydr Res; 1984 Mar; 126(2):338-42. PubMed ID: 6325002
[No Abstract] [Full Text] [Related]
9. Towards the synthesis of sialic acid-based Salmonella typhimurium sialidase inhibitors.
Angus DI; von Itzstein M
Carbohydr Res; 1995 Sep; 274():279-83. PubMed ID: 7585710
[No Abstract] [Full Text] [Related]
10. Inhibition of sialidase activity and cellular invasion by the bacterial vaginosis pathogen Gardnerella vaginalis.
Govinden G; Parker JL; Naylor KL; Frey AM; Anumba DOC; Stafford GP
Arch Microbiol; 2018 Sep; 200(7):1129-1133. PubMed ID: 29777255
[TBL] [Abstract][Full Text] [Related]
11. Chemoenzymatic synthesis of neuraminic acid analogs structurally varied at C-5 and C-9 as potential inhibitors of the sialidase from influenza virus.
Murakami M; Ikeda K; Achiwa K
Carbohydr Res; 1996 Jan; 280(1):101-10. PubMed ID: 8581891
[TBL] [Abstract][Full Text] [Related]
12. The synthesis of a series of deoxygenated 2,3-difluoro-N-acteylneuraminic acid derivatives as potential sialidase inhibitors.
Hader S; Watts AG
Carbohydr Res; 2013 Jun; 374():23-8. PubMed ID: 23618621
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation as sialidase inhibitors of xylo-configured cyclohexenephosphonates carrying glycerol side-chain mimics.
Streicher H
Bioorg Med Chem Lett; 2004 Jan; 14(2):361-4. PubMed ID: 14698159
[TBL] [Abstract][Full Text] [Related]
14. Streptococcus pneumoniae Sialidase SpNanB-Catalyzed One-Pot Multienzyme (OPME) Synthesis of 2,7-Anhydro-Sialic Acids as Selective Sialidase Inhibitors.
Xiao A; Slack TJ; Li Y; Shi D; Yu H; Li W; Liu Y; Chen X
J Org Chem; 2018 Sep; 83(18):10798-10804. PubMed ID: 30105908
[TBL] [Abstract][Full Text] [Related]
15. Analysis of sialidase and N-acetylneuraminate pyruvate-lyase substrate specificity by high-performance liquid chromatography.
Shukla AK; Schauer R
Anal Biochem; 1986 Oct; 158(1):158-64. PubMed ID: 2879483
[TBL] [Abstract][Full Text] [Related]
16. Multivalency and the mode of action of bacterial sialidases.
Thobhani S; Ember B; Siriwardena A; Boons GJ
J Am Chem Soc; 2003 Jun; 125(24):7154-5. PubMed ID: 12797770
[TBL] [Abstract][Full Text] [Related]
17. Phase-transfer-catalyzed synthesis of a phenylseleno alpha-ketoside of N-acetylneuraminic acid, (phenyl 5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-2- selenononulopyranosid)onic acid; a new sialidase inhibitor.
Rothermel J; Faillard H
Carbohydr Res; 1990 Dec; 208():251-4. PubMed ID: 2085812
[No Abstract] [Full Text] [Related]
18. The specificity of viral and bacterial sialidases for alpha(2-3)- and alpha(2-6)-linked sialic acids in glycoproteins.
Corfield AP; Higa H; Paulson JC; Schauer R
Biochim Biophys Acta; 1983 Apr; 744(2):121-6. PubMed ID: 6301560
[TBL] [Abstract][Full Text] [Related]
19. A novel synthetic reversible inhibitor of sialidase efficiently blocks secondary but not primary influenza virus infection of MDCK cells in culture.
Barrère B; Driguez PA; Maudrin J; Doutheau A; Aymard M; Quash G
Arch Virol; 1997; 142(7):1365-80. PubMed ID: 9267449
[TBL] [Abstract][Full Text] [Related]
20. Sialidases From
Wang YH
Front Cell Infect Microbiol; 2019; 9():462. PubMed ID: 31998664
[No Abstract] [Full Text] [Related]
[Next] [New Search]
